Ledger.Open graph →
SEC Form D · filed December 5, 2025

MindImmune Therapeutics, Inc

Offering
$12.0M
Sold
$10.2M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
KINGSTON, RI
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Christopher O'Donnell · Kingston, RIDirectorRobert B. Nelson · Kingston, RIExecIsaac Stoner · Cambridge, MAExec · DirectorReetika Bhardwaj · Kingston, RIDirectorBradley Margus · Kingston, RIDirectorRecurring Capital, LLC · Austin, TXDirectorAnthony Micali · New York, NYExecIsaac Stoner · Cambridge, MAExec · DirectorReetika Bhardwaj · Kingston, RIDirectorBradley Margus · Kingston, RIDirectorEric D. Tobias · Indianapolis, INExecBruce Lyman · McLean, VADirectorBarry Oates · Springville, UTExec · DirectorChristopher Buntel · Springville, UTDirectorDennis Decker · Springville, UTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗